TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies: Strong Buy Rating Backed by HEPLISAV-B Growth and Strategic Initiatives
TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25
JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Analyst Ratings
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Goldman Sachs Maintains Neutral on Dynavax Technologies, Lowers Price Target to $15
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. : The Dynavax Technologies (DVAX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $29.00.
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Dynavax Technologies Analyst Ratings
HC Wainwright & Co. : The Dynavax Technologies (DVAX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $29.00.
Dynavax Technologies: A Stable Hold Amidst a Catalyst-Deficient Forecast